Table 2 Serum biomarkers in the PLA and LC groups before and after 12 weeks of intervention. Data are presented as means ± SD
| Â | PLA | LC | Group x Time (p) | ||
|---|---|---|---|---|---|
pre | post | pre | post | ||
OPN (µg/L) | 19.8 ± 3.8 | 18.6 ± 2.8 | 18.4 ± 5.2 | 17.3 ± 6.2 | 0.954 |
SOST (ng/L) | 710 ± 445 | 704 ± 470 | 764 ± 500 | 647 ± 362 | 0.367 |
FGF-23 (ng/L) | 22.6 ± 21.3 | 25.8 ± 23.3 | 21.9 ± 18.0 | 22.9 ± 15.7 | 0.400 |
OPG (ng/L) | 142 ± 54 | 149 ± 51 | 146 ± 57 | 141 ± 44 | 0.460 |
DKK1 (ng/L) | 69.9 ± 14.3 | 69.9 ± 28.1 | 75.4 ± 26.5 | 74.4 ± 26.4 | 0.910 |
IGF-1 (µg/L) | 77.7 ± 14.5 | 82.9 ± 20.5 | 79.5 ± 25.9 | 85.3 ± 26.7 | 0.941 |
IL-6 (ng/L) | 1.6 ± 0.6 | 1.9 ± 0.8 | 1.8 ± 1.1 | 1.9 ± 1.4 | 0.566 |
TNF-α (ng/L) | 1.2 ± 0.3 | 1.1 ± 0.2 | 1.0 ± 0.3 | 1.0 ± 0.3 | 0.478 |
CRP (mg/L) | 2.3 ± 1.7 | 2.3 ± 2.1 | 2.3 ± 2.3 | 2.3 ± 2.4 | 0.970 |